LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.06 | 770.25 | 2736 | 3106 | 0.8808 | 0.8778 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 30.06 | 770.25 | 2670 | 3106 | 0.8596 | 0.8551 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.28 | 770.25 | 2935 | 3392 | 0.8651 | 0.8690 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 32.28 | 770.25 | 2847 | 3392 | 0.8391 | 0.8425 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.50 | 770.25 | 3138 | 3712 | 0.8454 | 0.8573 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 34.50 | 770.25 | 3023 | 3712 | 0.8144 | 0.8270 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.73 | 770.25 | 3402 | 4086 | 0.8326 | 0.8534 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 36.73 | 770.25 | 3230 | 4086 | 0.7905 | 0.8139 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.95 | 770.25 | 3674 | 4543 | 0.8086 | 0.8407 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 38.95 | 770.25 | 3505 | 4543 | 0.7714 | 0.8072 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.17 | 770.25 | 4004 | 5010 | 0.7991 | 0.8407 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 41.17 | 770.25 | 3792 | 5010 | 0.7568 | 0.8040 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 43.39 | 770.25 | 4243 | 5404 | 0.7851 | 0.8351 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 43.39 | 770.25 | 3978 | 5404 | 0.7361 | 0.7934 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 45.61 | 770.25 | 4581 | 5813 | 0.7881 | 0.8431 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 45.61 | 770.25 | 4245 | 5813 | 0.7303 | 0.7956 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.83 | 770.25 | 4820 | 6223 | 0.7745 | 0.8374 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 47.83 | 770.25 | 4557 | 6223 | 0.7322 | 0.8035 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 50.05 | 770.25 | 5187 | 6629 | 0.7824 | 0.8481 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 50.05 | 770.25 | 4792 | 6629 | 0.7228 | 0.8015 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 52.27 | 770.25 | 5525 | 7058 | 0.7827 | 0.8524 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 52.27 | 770.25 | 5115 | 7058 | 0.7246 | 0.8083 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 54.49 | 770.25 | 5893 | 7555 | 0.7800 | 0.8547 | MN20160304_L02 | K14 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 54.49 | 770.25 | 5375 | 7555 | 0.7114 | 0.8036 | MN20160304_L02 | L04 |
MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 56.71 | 770.25 | 6253 | 8001 | 0.7815 | 0.8592 | MN20160304_L02 | K14 |